Publications

Journal Article Ppublish 72 citations
Electronic publication date
October 21, 2005

View on Pubmed.gov 16153225 | View on doi.org 10.1111/j.1464-...

Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension.

Search for publications in this journal BJU Int - 96(6):895-9

Abstract

OBJECTIVES

To evaluate the significance of clusterin expression in surgically resected renal cell carcinoma (RCC) specimens.

PATIENTS AND METHODS

Normal kidney and RCC specimens were obtained from 131 patients who had radical surgery. The expression of clusterin protein was analysed by immunohistochemical staining with an antibody recognizing all isoforms of clusterin. Cell proliferative activities and apoptotic features in these specimens were investigated using Ki-67 immunostaining and the terminal deoxynucleotidyl transferase mediated dUTP nick-end labelling assay, respectively. Findings were evaluated in relation to several clinicopathological factors.

RESULTS

There were various levels of clusterin expression in 128 of the 131 RCC specimens, while 37 of 131 normal kidney tissues (28.2%) had no clusterin staining. Clusterin protein was present in the cytoplasm of both normal and cancer cells, but there was no nuclear staining identified in either type of cell. The expression level of clusterin protein in RCC tissues was significantly related to tumour stage and grade, but not to age, gender or histological cell type. Cell proliferative activity in RCC specimens was significantly associated with clusterin expression, while the apoptotic index was inversely related to clusterin expression. Furthermore, recurrence-free survival in patients with strong clusterin expression was significantly lower than that in those with weak expression.

CONCLUSIONS

These findings suggest that the secreted form of clusterin may be involved in the progression of RCC, and that overexpression of clusterin could be a useful prognostic variable after radical surgery in patients with RCC.

References

No references provided.

Cited by 72 citations (total)

Journal Article

Association between clusterin polymorphisms and esophageal squamous cell carcinoma risk in Han Chinese population.

Electronic publication date November 10, 2015

Search for publications in this journal Int J Clin Exp Med

Kun Li [...] Guang-Hong Guo et al.

Genetic susceptibility plays an essential role in an individual's risk of esophageal squamous cell carcinoma (ESCC). The aim of this...

Journal Article Research Support, Non-U.S. Gov't

eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.

Electronic publication date February 15, 2017

Search for publications in this journal Oncotarget

Ji-Yeon Lee [...] Seung-Hoon Lee et al.

Clusterin is a secretory heterodimeric glycoprotein and the overexpression of secretory clusterin (sCLU) promotes cancer cell proliferation and reduces chemosensitivity....

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances